GPER expressed on microglia mediates the anti‐inflammatory effect of estradiol in ischemic stroke

Abstract Background Stroke could lead to serious morbidity, of which ischemic stroke counts for majority of the cases. Inflammation plays an important role in the pathogenesis of ischemic stroke, thus drugs targeting inflammation could be potentially neuroprotective. Estradiol was shown to be neuroprotective as well as anti‐inflammatory in animal models of ischemic stroke with unclear mechanism. We hypothesize that the anti‐inflammatory and neuroprotective effect of estradiol is mediated by the estradiol receptor G protein‐coupled estrogen receptor 1 ( GPER ) expressed on microglia. Methods We have generated the rat global cerebral ischemic model and the primary microglia culture to study the neuroprotective and anti‐inflammatory effect of estradiol. We have further used pharmacological methods and si RNA knockdown approach to study the underlying mechanism. Results We found that estradiol reduced the level of proinflammatory cytokines including IL ‐1 β and TNF ‐ α , both in vivo and in vitro. We also found that the specific GPER agonist G1 could reduce the level of IL ‐1 β ( P  = 0 P  = 0.0017, one‐way ANOVA and post hoc test) and TNF ‐ α ( P  < 0.0001) in the primary microglia culture. Moreover, the specific GPER antagonist G15 was able to abolish the anti‐inflammatory effect of estradiol. Estradiol failed to reduce the level of IL ‐1 β ( P  = 0.4973, unpaired Student's t ‐test) and TNF ‐ α ( P  = 0.1627) when GPER was knocked down. Conclusions Our studies have suggested that GPER expressed on microglia mediated the anti‐inflammatory effect of estradiol after ischemic stroke. Our studies could potentially help to develop more specific drugs to manage inflammation postischemic stroke.